A. Michallet Et Al. , "Rituximab in combination with bendamustine or chlorambucil for the treatment of chronic lymphocytic leukemia: primary results from the randomised phase IIIb MABLE study," LEUKEMIA & LYMPHOMA , vol.56, pp.149, 2015
Michallet, A. Et Al. 2015. Rituximab in combination with bendamustine or chlorambucil for the treatment of chronic lymphocytic leukemia: primary results from the randomised phase IIIb MABLE study. LEUKEMIA & LYMPHOMA , vol.56 , 149.
Michallet, A., Aktan, M., Schuh, A., Widenius, T., Johansson, P., Raposo, J., ... Meddeb, B.(2015). Rituximab in combination with bendamustine or chlorambucil for the treatment of chronic lymphocytic leukemia: primary results from the randomised phase IIIb MABLE study. LEUKEMIA & LYMPHOMA , vol.56, 149.
Michallet, Anne-Sophie Et Al. "Rituximab in combination with bendamustine or chlorambucil for the treatment of chronic lymphocytic leukemia: primary results from the randomised phase IIIb MABLE study," LEUKEMIA & LYMPHOMA , vol.56, 149, 2015
Michallet, Anne-Sophie Et Al. "Rituximab in combination with bendamustine or chlorambucil for the treatment of chronic lymphocytic leukemia: primary results from the randomised phase IIIb MABLE study." LEUKEMIA & LYMPHOMA , vol.56, pp.149, 2015
Michallet, A. Et Al. (2015) . "Rituximab in combination with bendamustine or chlorambucil for the treatment of chronic lymphocytic leukemia: primary results from the randomised phase IIIb MABLE study." LEUKEMIA & LYMPHOMA , vol.56, p.149.
@article{article, author={Anne-Sophie Michallet Et Al. }, title={Rituximab in combination with bendamustine or chlorambucil for the treatment of chronic lymphocytic leukemia: primary results from the randomised phase IIIb MABLE study}, journal={LEUKEMIA & LYMPHOMA}, year=2015, pages={149} }